Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2010-11-5
pubmed:databankReference
pubmed:abstractText
Increasing rates of failure of artemisinin-based combination therapy have highlighted the possibility of emerging artemisinin resistance along the Thai-Cambodian border. We used an integrated in vivo-in vitro approach to assess the presence of artemisinin resistance in western Cambodia. This article provides additional data from a clinical trial that has been published in The New England Journal of Medicine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1537-6591
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e82-9
pubmed:meshHeading
pubmed-meshheading:21028985-Adolescent, pubmed-meshheading:21028985-Adult, pubmed-meshheading:21028985-Aged, pubmed-meshheading:21028985-Antimalarials, pubmed-meshheading:21028985-Artemisinins, pubmed-meshheading:21028985-Cambodia, pubmed-meshheading:21028985-Drug Resistance, pubmed-meshheading:21028985-Female, pubmed-meshheading:21028985-Humans, pubmed-meshheading:21028985-Malaria, Falciparum, pubmed-meshheading:21028985-Male, pubmed-meshheading:21028985-Middle Aged, pubmed-meshheading:21028985-Parasitemia, pubmed-meshheading:21028985-Plasma, pubmed-meshheading:21028985-Plasmodium falciparum, pubmed-meshheading:21028985-Quinine, pubmed-meshheading:21028985-Recurrence, pubmed-meshheading:21028985-Tetracycline, pubmed-meshheading:21028985-Thailand, pubmed-meshheading:21028985-Treatment Failure, pubmed-meshheading:21028985-Young Adult
pubmed:year
2010
pubmed:articleTitle
Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia.
pubmed:affiliation
Institute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't